Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond F Schinazi

Showing results (1-10 of 422) with videos related to

Pageof 43
Sort By:
Antiviral Chemistry & Chemotherapy|July 7, 2011
William H Prusoff dies at 90 - a renaissance man that revolutionized the treatment of herpesviruses and HIVRaymond F Schinazi
Journal of Acquired Immune Deficiency Syndromes (1999)|October 4, 2003
Assessment of the relative potency of emtricitabine and lamivudineRaymond F Schinazi
Science (New York, N.Y.)|February 3, 2022
Lethal mutagenesis as an antiviral strategyRonald Swanstrom, Raymond F Schinazi
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2017
From HCV To HBV CureRaymond F Schinazi, Tarik Asselah
Antiviral Chemistry & Chemotherapy|November 27, 2002
Hepatitis B virus resistance to lamivudine and its clinical implicationsXuefeng Liu, Raymond F Schinazi
Farmaco (Societa Chimica Italiana : 1989)|February 5, 2003
Synthesis of oxathiolane imidazole nucleosidesAyse Kocabalkanli, Raymond F Schinazi
Antiviral Chemistry & Chemotherapy|October 22, 2009
Antiretroviral therapy in macrophages: implication for HIV eradicationChristina Gavegnano, Raymond F Schinazi
Antiviral Research|October 9, 2002
Development of a pharmacodynamic model for HIV treatment with nucleoside reverse transcriptase and protease inhibitorsSelwyn J Hurwitz, Raymond F Schinazi
Antiviral Research|August 31, 2011
In silico study supports the efficacy of a reduced dose regimen for stavudineSelwyn J Hurwitz, Raymond F Schinazi
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2013
Best strategies for global HCV eradicationLiesl M Hagan, Raymond F Schinazi
Pageof 43

Showing results (1-10 of 422) with videos related to

Sort By:
Pageof 43
Antiviral Chemistry & Chemotherapy|July 7, 2011
William H Prusoff dies at 90 - a renaissance man that revolutionized the treatment of herpesviruses and HIVRaymond F Schinazi
Journal of Acquired Immune Deficiency Syndromes (1999)|October 4, 2003
Assessment of the relative potency of emtricitabine and lamivudineRaymond F Schinazi
Science (New York, N.Y.)|February 3, 2022
Lethal mutagenesis as an antiviral strategyRonald Swanstrom, Raymond F Schinazi
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2017
From HCV To HBV CureRaymond F Schinazi, Tarik Asselah
Antiviral Chemistry & Chemotherapy|November 27, 2002
Hepatitis B virus resistance to lamivudine and its clinical implicationsXuefeng Liu, Raymond F Schinazi
Farmaco (Societa Chimica Italiana : 1989)|February 5, 2003
Synthesis of oxathiolane imidazole nucleosidesAyse Kocabalkanli, Raymond F Schinazi
Antiviral Chemistry & Chemotherapy|October 22, 2009
Antiretroviral therapy in macrophages: implication for HIV eradicationChristina Gavegnano, Raymond F Schinazi
Antiviral Research|October 9, 2002
Development of a pharmacodynamic model for HIV treatment with nucleoside reverse transcriptase and protease inhibitorsSelwyn J Hurwitz, Raymond F Schinazi
Antiviral Research|August 31, 2011
In silico study supports the efficacy of a reduced dose regimen for stavudineSelwyn J Hurwitz, Raymond F Schinazi
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2013
Best strategies for global HCV eradicationLiesl M Hagan, Raymond F Schinazi
Pageof 43